Table 5.
Characteristics | IBS (−) BMI < 30 | IBS (−) BMI ≥ 30 | IBS (+) BMI < 30 | IBS (+) BMI ≥ 30 | p |
---|---|---|---|---|---|
n (%) | 272 (63.1) | 113 (26.2) | 33 (7.7) | 13 (3.0) | |
AIS | |||||
Total score | 4.07 ± 3.51 | 5.12 ± 3.77 | 7.03 ± 3.82 | 10.92 ± 6.90 | <0.001 |
Total score ≥ 6, n (%) | 75 (27.6) | 44 (38.9) | 22 (66.7) | 9 (69.2) | <0.001 (for trend) |
Risk of AIS ≥ 6, OR (95% CI) | 1 | 1.68 (1.06–2.66) | 5.20 (2.41–11.24) | 5.91 (1.77–19.77) | |
BSRS-5 | |||||
Total score | 3.85 ± 3.46 | 4.93 ± 3.90 | 6.42 ± 4.04 | 8.00 ± 5.70 | <0.001 |
Total score ≥ 10, n (%) | 25 (9.2) | 14 (12.4) | 6 (18.2) | 4 (30.8) | 0.009 (for trend) |
Risk of BSRS-5 ≥ 10, OR (95% CI) | 1 | 1.40 (0.70–2.80) | 2.18 (0.82–5.78) | 4.39 (1.26–15.29) |
a. AIS, Athens Insomnia Scale; BMI, body mass index; BSRS-5, Brief Symptom Rating Scale; CI, confidence interval; IBS, irritable bowel syndrome; OR, odds ratio; PCOS, polycystic ovary syndrome.
b. The Mantel–Haenszel test was used to test the linear trend for statistical significance.
c. p < 0.05 indicates statistical significance.